INNOVADERM CRO IS NOW INDERO.
READ THE ANNOUNCEMENT
Talk to us

Topic: Early Phase

Episode 42: Ana Palijan – Basket Trials Require a High Level of Operational Expertise Upfront

Innovaderm to Indero

We sat down with Ana Palijan, Senior Director of Early Phase and Translational Research at Indero. She’s a strategic clinical development leader and innovating disruptor with almost 20 years’ experience spanning early phase clinical development, translational research, and biomarker-driven programs across many therapeutic areas, currently dermatology, and author of more than 40 peer-reviewed publications.  Today, we’re talking about […]

Systemic Sclerosis Case Study

Click here for a PDF version of this case study Indero helped optimize recruitment and logistics for this systemic sclerosis (SSc) study. Outcomes Effective study design and patient management leading to 96% patient retention Patient recruitment was completed on time without any advertisement despite longer timelines associated with academic sites and the institutional burden   […]

Episode 37: Simon Grant (Ascilion) & ThĂ©o Boyer – ISF: A New Dimension in Skin Biomarkers

Innovaderm to Indero

Resources:  [email protected]: Use this email to let us know what you want to hear about.  https://www.ascilion.com/    This episode explores the future of skin biomarkers. Featuring insights from Simon Grant, CEO of Ascilion, and ThĂ©o Boyer, Senior Project Coordinator at Indero, the episode examines how dermal interstitial fluid (d-ISF) could revolutionize dermatology. Our guests illuminate […]

Early Phase Trials: More Than Just Safety

  Early phase clinical trials are no longer limited to assessing safety, they have become a foundation for strategic decision-making in drug development. Dr. Ana Palijan, Director of Early Phase and Translational Research at Indero, explores how these trials have evolved in scope and complexity. With over 25 years of experience in translational and early phase […]

Interview with Dr. Robert Bissonnette: Indero Introduces New Early Phase 1 Model for Topical NCEs, Shortening Study Duration from 8-12 Weeks to ≀3 Days

  In this exclusive interview, Dr. Robert Bissonnette shares insights from Indero’s internally-led study, which introduces a novel approach to early phase topical drug evaluation. By leveraging quantitative gene expression analysis and non-invasive tape strip sampling, this method promises to transform the assessment of new chemical entities (NCEs), offering rapid, cost-effective, and patient-friendly solutions for […]

Innovative Approaches to Study Design in Early Phase Dermatology Trials

dermatology early phase clinical trial

Early phase clinical trials mark the transition from preclinical research to clinical application, characterized by unique challenges and opportunities. Key considerations include the difference between early and late phase trials, the importance of data quality, and the specialized techniques used in dermatology. Key Differences Between Early and Late Phase Trials The true distinction lies in […]

Urticaria Case Study

Click here for a PDF version of this case study Outcomes Indero successfully rescued this urticaria study and this resulted in: Recruitment on Time The study was completed successfully, demonstrating Indero’s ability to manage early phase international clinical trials. Client Feedback “We have had strong project director support which contributed to the successful collaboration between the […]

Atopic Dermatitis (AD) Rescue Case Study

Click here for a PDF version of this case study Indero supported the rescue of a Phase 2a atopic dermatitis trial. Outcomes Indero successfully rescued this AD study, resulting in: 215% enrollment increase in half the time Dramatic improvement of site engagement   Study Characteristics Study Phase: 2a Patient population: Atopic dermatitis IP Route of administration: […]

Talk to us